http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015261626-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18726312eff9eb2bd2f380dd8189ec20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4168 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2015-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6781183c192684db3717a6f3c7fb795 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f19fb66144a90500a1c7aeeec460470f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10837053b591e31ab8f8c414ba34d55c |
| publicationDate | 2015-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2015261626-A1 |
| titleOfInvention | Combination treatment for Rosacea |
| abstract | H:\dxBlnavlover KRPorthl\DCC\RBR 8950918_ Ldoc: -251 2015 The invention relates to a method of treating erythema and/or telangiectasia associated with rosacea in a patient in need thereof by topically administering an effective amount of a 5 combination of brimonidine or a pharmaceutically acceptable salt thereof and oxymetazoline or a pharmaceutically acceptable salt thereof to the site of erythema and/or telangiectasia on the skin of the patient. The invention further relates to topical compositions including the combination of compounds and a pharmaceutically acceptable carrier. |
| priorityDate | 2010-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 149.